Edition:
United States

Profile: JW Holdings Corp (096760.KS)

096760.KS on Korea Stock Exchange

16,100.00KRW
8:11pm EDT
Change (% chg)

₩-100.00 (-0.62%)
Prev Close
₩16,200.00
Open
₩16,450.00
Day's High
₩16,550.00
Day's Low
₩16,100.00
Volume
133,527
Avg. Vol
568,672
52-wk High
₩16,550.00
52-wk Low
₩7,070.00

JW HOLDINGS CORPORATION is a Korea-based holding company mainly engaged in the subsidiary management and pharmaceutical distribution businesses. The Company's products are imipenem, itraconazole, nutrients fluids, general fluids and others. Its subsidiaries include JW PHARMACEUTICAL CORPORATION, engaged in the manufacture of pharmaceuticals, such as diabetic agents, urology agents, nephrology agents and others; JW SHINYAK CORPORATION, engaged in the manufacture of pharmaceuticals, such as antibiotics, skin drugs, obesity drugs, allergy drugs and others, and JW Medical Corporation, engaged in the manufacture of medical equipment, such as magnetic resonance imaging (MRI) equipment, computed tomography (CT) equipment and others, among others.

Company Address

JW Holdings Corp

2477, Nambusunhwan-ro, Seocho-gu
SEOUL     06725
P: +822.8406777
F: +822.8437696

Company Web Links